These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 10579678)
1. An investigation into the erosion behaviour of a high drug-load (85%) particulate system designed for an extended-release matrix tablet. Analysis of erosion kinetics in conjunction with variations in lubrication, porosity and compaction rate. Dürig T; Venkatesh GM; Fassihi R J Pharm Pharmacol; 1999 Oct; 51(10):1085-92. PubMed ID: 10579678 [TBL] [Abstract][Full Text] [Related]
2. Mechanistic evaluation of binary effects of magnesium stearate and talc as dissolution retardants at 85% drug loading in an experimental extended-release formulation. Dürig T; Fassihi R J Pharm Sci; 1997 Oct; 86(10):1092-8. PubMed ID: 9344163 [TBL] [Abstract][Full Text] [Related]
3. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications. Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316 [TBL] [Abstract][Full Text] [Related]
4. Cogrinding as a tool to produce sustained release behavior for theophylline particles containing magnesium stearate. Nokhodchi A; Okwudarue ON; Valizadeh H; Momin MN AAPS PharmSciTech; 2009; 10(4):1243-51. PubMed ID: 19862623 [TBL] [Abstract][Full Text] [Related]
5. Plasticisation of amylodextrin by moisture: consequences for drug release from tablets. Steendam R; Eissens AC; Frijlink HW; Lerk CF Int J Pharm; 2000 Aug; 204(1-2):23-33. PubMed ID: 11011982 [TBL] [Abstract][Full Text] [Related]
6. Understanding and optimizing the dual excipient functionality of sodium lauryl sulfate in tablet formulation of poorly water soluble drug: wetting and lubrication. Aljaberi A; Chatterji A; Dong Z; Shah NH; Malick W; Singhal D; Sandhu HK Pharm Dev Technol; 2013; 18(2):490-503. PubMed ID: 23009028 [TBL] [Abstract][Full Text] [Related]
7. The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution. Calahan JL; Paul S; Yanez EG; DeNeve D; Sun CC; Munson EJ Pharm Dev Technol; 2021 Feb; 26(2):150-156. PubMed ID: 33267700 [TBL] [Abstract][Full Text] [Related]
8. A new experimental design method to optimize formulations focusing on a lubricant for hydrophilic matrix tablets. Choi du H; Shin S; Khoa Viet Truong N; Jeong SH Drug Dev Ind Pharm; 2012 Sep; 38(9):1117-27. PubMed ID: 22348254 [TBL] [Abstract][Full Text] [Related]
9. Application of external lubrication during the roller compaction of adhesive pharmaceutical formulations. Dawes J; Allenspach C; Gamble JF; Greenwood R; Robbins P; Tobyn M Pharm Dev Technol; 2013 Feb; 18(1):246-56. PubMed ID: 22813432 [TBL] [Abstract][Full Text] [Related]
10. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate. Ferrero C; Jiménez-Castellanos MR Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices. Ghori MU; Ginting G; Smith AM; Conway BR Int J Pharm; 2014 Apr; 465(1-2):405-12. PubMed ID: 24560637 [TBL] [Abstract][Full Text] [Related]
12. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction. Chansanroj K; Betz G Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913 [TBL] [Abstract][Full Text] [Related]
13. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics. Marinich JA; Ferrero C; Jiménez-Castellanos MR Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473 [TBL] [Abstract][Full Text] [Related]
14. Development of matrix-based theophylline sustained-release microtablets. Rey H; Wagner KG; Wehrlé P; Schmidt PC Drug Dev Ind Pharm; 2000 Jan; 26(1):21-6. PubMed ID: 10677806 [TBL] [Abstract][Full Text] [Related]
15. Particle size distribution and evolution in tablet structure during and after compaction. Fichtner F; Rasmuson A; Alderborn G Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568 [TBL] [Abstract][Full Text] [Related]
16. A study on maize proteins as a potential new tablet excipient. Georget DM; Barker SA; Belton PS Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824 [TBL] [Abstract][Full Text] [Related]
17. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride. Rajesh KS; Venkataraju MP; Gowda DV Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235 [TBL] [Abstract][Full Text] [Related]
18. Controlled release of theophylline monohydrate from amylodextrin tablets: in vitro observations. Van der Veen J; Te Wierik GH; Van der Wal L; Eissens AC; Lerk CF Pharm Res; 1994 Apr; 11(4):499-502. PubMed ID: 8058604 [TBL] [Abstract][Full Text] [Related]
19. Mechanochemical effect on swelling and drug release of natural polymer matrix tablets by X-ray computed tomography. Hattori Y; Takaku T; Otsuka M Int J Pharm; 2018 Mar; 539(1-2):31-38. PubMed ID: 29366946 [TBL] [Abstract][Full Text] [Related]
20. Commercial scale validation of a process scale-up model for lubricant blending of pharmaceutical powders. Kushner J; Schlack H Int J Pharm; 2014 Nov; 475(1-2):147-55. PubMed ID: 25152166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]